Have a personal or library account? Click to login
How we investigate drug-induced immune hemolytic anemia Cover

How we investigate drug-induced immune hemolytic anemia

Immunohematology
Volume 30 (2014): Issue 2 (June 2014)
By: R.M. Leger,  P.A. Arndt and  G. Garratty  
Paid access
|Nov 2019

Authors

R.M. Leger

American Red Cross Blood Services, Southern California Region, Pomona, CA, United States

P.A. Arndt

American Red Cross Blood Services, Southern California Region, Pomona, CA, United States

G. Garratty

American Red Cross Blood Services, Southern California Region, Pomona, CA, United States
DOI: https://doi.org/10.21307/immunohematology-2019-102 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 85 - 94
Published on: Nov 6, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
immune hemolytic anemia,
drugs,
antibodies,
drug-treated red blood cells,
testing in presence of drug,
penicillin,
cephalosporin,
antibiotics
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2019 R.M. Leger, P.A. Arndt, G. Garratty, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 30 (2014): Issue 2 (June 2014)Next article